D
Coeptis Therapeutics Holdings, Inc. COEP
$9.47 $0.101.07%
Recommendation
Sell
Prev Close
$9.38
Volume
9,828
Avg Vol (90D)
280,944
Market Cap
$26.71M
Dividend & Yield
--
52-Week Range
$2.31 - $13.70
P/E (TTM)
--
EPS (TTM)
-$6.44
My Lists My Alerts
Rating
Reward
E
Very Weak
Risk
D
Weak
Rating Factors
Growth Index
Fair
Efficiency Index
Very Weak
Solvency Index
Fair
Total Return Index
Weak
Volatility Index
Weak
Dividend Index
--
Headlines
Coeptis Therapeutics Holdings, Inc. (NASDAQ:COEP) Sees Large Growth in Short Interest
3/14/2025 - Ticker Report
Coeptis Therapeutics Secures Worldwide Development and Commercialization Rights to Next-Generation GEAR Cell Therapy Platform Strengthening its High-Impact Precision Immuno-Oncology Pipeline
3/11/2025 - Globe Newswire
COEPTIS' NexGenAI Affiliates Partners with NUBURU Network to Drive Innovation in AI and Robotics as Part of its Transformation Plan
3/7/2025 - Globe Newswire
Coeptis Therapeutics Holdings, Inc. (NASDAQ:COEP) Sees Large Decrease in Short Interest
3/5/2025 - Ticker Report
Top 9 AI News and Ratings Sending Shockwaves
2/21/2025 - Insider Monkey
Coeptis Therapeutics Holdings Inc trading resumes
2/20/2025 - TipRanks Financial Blog
Coeptis Therapeutics Holdings Inc trading resumes
2/20/2025 - The Fly
Coeptis Therapeutics Holdings Inc trading halted, volatility trading pause
2/20/2025 - TipRanks Financial Blog
Coeptis Therapeutics Holdings Inc trading halted, volatility trading pause
2/20/2025 - The Fly
COEPTIS' NexGenAI Partners with Arketyp Valu to Revolutionize Digital Engagement on the Verus Network
2/20/2025 - Globe Newswire
COEPTIS NexGenAI Affiliates Network & MarketLeverage Announce Strategic Partnership to Revolutionize AI-Powered Affiliate Marketing
2/20/2025 - Globe Newswire
COEPTIS NexGenAI Affiliates Network & MarketLeverage Announce Strategic Partnership to Revolutionize AI-Powered Affiliate Marketing
2/19/2025 - Globe Newswire
Top 10 Must-See AI News And Ratings For Investors
2/13/2025 - Insider Monkey
COEPTIS Announces the Launch of COEP Venture Group to Invest in AI, RPA, and AI Agent Startups
2/13/2025 - Globe Newswire
Coeptis Therapeutics Holdings, Inc. (COEP) Raises $10M to Advance AI-Driven Cell Therapy Innovations
2/8/2025 - Insider Monkey
10 AI News Updates Making Waves on Wall Street
2/6/2025 - Insider Monkey
COEPTIS Completes $10 Million Series A Preferred Financing Round, Reinforcing Commitment to Technological Innovation and AI Integration
2/6/2025 - PR Newswire
Coeptis Therapeutics Holdings, Inc. (COEP): Pioneering AI-Powered Marketing for Healthcare Innovation
1/31/2025 - Insider Monkey
Coeptis Therapeutics Holdings Becomes COEPTIS: Embracing a Future of Technology and Innovation
1/30/2025 - GuruFocus
Coeptis Therapeutics Holdings Becomes COEPTIS: Embracing a Future of Technology and Innovation
1/30/2025 - PR Newswire
Coeptis Therapeutics Holdings Inc trading resumes
1/23/2025 - TipRanks Financial Blog
Coeptis Therapeutics Holdings Inc trading resumes
1/23/2025 - The Fly
Coeptis Therapeutics Holdings Inc trading halted, volatility trading pause
1/23/2025 - TipRanks Financial Blog
Coeptis Therapeutics Holdings Inc trading halted, volatility trading pause
1/23/2025 - The Fly
Coeptis Therapeutics Leverages Artificial Intelligence and Blockchain for Next-Generation Innovation
1/23/2025 - PR Newswire
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
-$10.26M
EBIT (TTM)
-$11.26M
Net Income (TTM)
-$11.62M
Balance Sheet
Total Assets (Q)
$8.96M
Total Debt (Q)
$1.78M
Total Liabilities (Q)
$3.97M
Book Value Per Share (Q)
$2.41
Cash Flow
Cash from Operations (TTM)
-$6.91M
Cash from Investing (TTM)
-$100.00K
Cash from Financing (TTM)
$6.73M
Net Change in Cash (TTM)
-$274.10K
Filings
Filing Date
Wednesday, November 13, 2024
Period Date
Monday, September 30, 2024
Next Filing
Week of Aug 11 and 15 (est)
Price History
Loading...
Beta
1.59
7-Day Total Return
-3.37%
30-Day Total Return
-23.94%
60-Day Total Return
72.18%
90-Day Total Return
137.94%
Year to Date Total Return
60.24%
1-Year Total Return
60.51%
2-Year Total Return
-71.65%
3-Year Total Return
-95.30%
5-Year Total Return
--
52-week Low
Dec 31, 2024 - $2.31
52-week High
Jan 30, 2025 - $13.70
Valuation
Market Cap
$26.71M - Nano Cap
Enterprise Value
$27.51M
Price/Sales (TTM)
--
Price/Book (Q)
3.89
Dividends and Shares
Shares Outstanding
1.99M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
coeptistx.com
Phone Number
724 934 6467
Address
105 Bradford Road
Wexford, PA 15090
Country
United States
Year Founded
2017
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Coeptis Therapeutics Holdings, Inc., together with its subsidiaries, operates as a biopharmaceutical company. It is developing cell therapy platforms for cancer, autoimmune, and infectious... more
NASDAQ 04/01/2025 4:00PM Eastern Quotes delayed
Weiss Ratings